Axonis_US Profile Banner
Axonis Therapeutics, Inc. Profile
Axonis Therapeutics, Inc.

@Axonis_US

Followers
181
Following
80
Media
18
Statuses
79

Axonis Therapeutics is a Boston-based, neuro-focused biotechnology company developing first- and best-in-class medicines targeting KCC2.

Boston MA, USA
Joined March 2019
Don't wanna be here? Send us removal request.
@Axonis_US
Axonis Therapeutics, Inc.
9 months
Thrilled to share that the New York Stock Exchange celebrated our Series A financing on the trading floor after yesterday’s opening bell. Thanks, @NYSE for the recognition!
Tweet media one
1
1
4
@Axonis_US
Axonis Therapeutics, Inc.
9 months
The Axonis team is very excited to announce we’ve raised a $115 million series A financing to support the development of novel neuromedicines targeting KCC2, including our lead program AXN-027 for epilepsy and pain. Read our press release:
Tweet media one
0
4
7
@Axonis_US
Axonis Therapeutics, Inc.
10 months
RT @OrphanConf: Join us in welcoming #WorldOrphanUSA's latest & greatest speaker additions: @RhythmPharma, @amf41, @CNSdrughunter, @SVH_neu….
0
3
0
@Axonis_US
Axonis Therapeutics, Inc.
1 year
RT @ISS_CASIS: During a fireside chat, attendees at #ISSRDC heard the many ways startups can access the space environment to conduct innova….
0
4
0
@Axonis_US
Axonis Therapeutics, Inc.
1 year
RT @SVH_neuro: Excited to participate in this fireside chat! #TechnologyInSpace award is special opportunity to push boundaries of #science….
0
1
0
@Axonis_US
Axonis Therapeutics, Inc.
1 year
RT @BiotechTVHQ: Spinal Cord Injury Investor Symposium: The CEO of @Axonis_US discusses the importance of KCC2 inhibition in CNS disorders.….
0
1
0
@Axonis_US
Axonis Therapeutics, Inc.
1 year
RT @LongwoodLeaders: Terrific discussion on what it takes to progress science with Teresa Bitetti @TakedaPharma @skathire @vervetx John L….
0
3
0
@Axonis_US
Axonis Therapeutics, Inc.
1 year
RT @cureSYNGAP1: Dr. Shilpa Kadam has joined our SAB - Welcome! Dr. Kadam is a skilled translational scientist with @Axonis_US, interested….
0
2
0
@Axonis_US
Axonis Therapeutics, Inc.
2 years
RT @BetsyPilon: I also got to meet @CureEpilepsy awardee Dr Shilpa Kadam in person! Shilpa has done INCREDIBLE preclinical research with #H….
0
3
0
@Axonis_US
Axonis Therapeutics, Inc.
2 years
RT @SVH_neuro: Proud @Axonis_US #research onboard @Space_Station was featured @WSJbusiness. Appreciate @NASA support to push boundaries of….
Tweet card summary image
wsj.com
Removing gravity allows researchers to do experiments they could never duplicate on the ground.
0
1
0
@Axonis_US
Axonis Therapeutics, Inc.
2 years
RT @BoeingSpace: Think your idea or company has no business in space? Think again!. Hear from Tech in Space winner, @Axonis_US, about how #….
0
13
0
@Axonis_US
Axonis Therapeutics, Inc.
2 years
RT @ISS_Research: Science is launching to the @Space_Station! 🚀. While you wait for August 1, read more about this science including studie….
Tweet card summary image
nasa.gov
The 19th Northrop Grumman mission include studies of fire suppression, gene therapy, atmospheric monitoring, and space-flown student artwork
0
10
0
@Axonis_US
Axonis Therapeutics, Inc.
2 years
RT @ISS_CASIS: Biotech #startup @Axonis_US is launching research to the @Space_Station to help those on Earth affected by neurological diso….
0
12
0
@Axonis_US
Axonis Therapeutics, Inc.
2 years
RT @SVH_neuro: Honor to discuss @Axonis_US project at International #Space Station National Laboratory on @NASA NG-19 #mission. Leveraging….
0
1
0
@Axonis_US
Axonis Therapeutics, Inc.
2 years
RT @SVH_neuro: Improving #Precision #Neuroscience on @NASA 'Houston We Have a #Podcast'! Discussed @Axonis_US #project about to launch to @….
0
1
0
@Axonis_US
Axonis Therapeutics, Inc.
2 years
RT @CureEpilepsy: Congratulations to our newest grantees! Learn more about their work and how it will impact the epilepsy community: https:….
0
3
0
@Axonis_US
Axonis Therapeutics, Inc.
2 years
RT @SVH_neuro: Look forward to @Syngap1Fnd 1st Industry Round Table on #drug development for #SYNGAP1 & related #neurological #disorders. W….
0
1
0